KTKemmons A. Tubbs

Kemmons A. Tubbs

*This is an algorithmically generated author record based on publicly available information.

Kemmons A. Tubbs has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Allan L. Bieber

    Intrinsic Bioprobes, Inc., 625 South Smith Road, Suite 22, Tempe, Arizona 85281, and Department of Chemistry and Biochemistry, Arizona State University, Tempe, Arizona 85287-1604

    2 shared publications
  • Dobrin Nedelkov

    Intrinsic Bioprobes, Inc., 625 South Smith Road, Suite 22, Tempe, Arizona 85281, and Department of Chemistry and Biochemistry, Arizona State University, Tempe, Arizona 85287-1604

    2 shared publications
  • Dobrin Nedelkov

    Intrinsic Bioprobes, Tempe, AZ, USA

    2 shared publications
  • Eric E. Niederkofler

    Intrinsic Bioprobes, Inc., 625 South Smith Road, Suite 22, Tempe, Arizona 85281, and Department of Chemistry and Biochemistry, Arizona State University, Tempe, Arizona 85287-1604

    2 shared publications
  • Eric E. Niederkofler

    Intrinsic Bioprobes, Inc., 2155 E. Conference Drive, Suite 104, Tempe, AZ 85284, USA

    2 shared publications
  • Randall W. Nelson

    Intrinsic Bioprobes, Inc., 625 South Smith Road, Suite 22, Tempe, Arizona 85281, and Department of Chemistry and Biochemistry, Arizona State University, Tempe, Arizona 85287-1604

    2 shared publications

Latest Publications

  • The Study of Microheterogeneity in Human Plasma Proteins: Application to Acute Myocardial Infarction

    by Randall W. Nelson, Urban A. Kiernan, Dobrin Nedelkov, Kemmons A. Tubbs, Eric E. Niederkofler

  • Development of Recombinant-Based Mass Spectrometric Immunoassay with Application to Resistin Expression Profiling

    by Kemmons A. Tubbs, Urban A. Kiernan, Eric E. Niederkofler, Dobrin Nedelkov, Allan L. Bieber, Randall W. Nelson

    This report addresses the need for additional assays for human resistin (hRES) by developing a rational progression of the mass spectrometric immunoassay to incorporate recombinant proteins. The recombinant-based hRES mass spectrometric immunoassay (RES-MSIA) was initially developed for the qualitative analysis of the human resistin homodimer from normal (healthy) plasma samples. The method involved selective extraction and detection of both endogenous and recombinant resistant proteins. RES-MSIA was then applied to the rigorous quantification of resistin. The resistin standard addition curve was constructed from serially diluted concentrations of rhRES using endogenous hRES, inherent in the human plasma, as the internal reference standard (IRS). The roles of endogenous and recombinant resistin were subsequently reversed, using rhRES as the IRS during RES-MSIA quantification. Concurrently, the relative ratio of hRES to rhRES was used as an ancillary technique to rapidly determine the relative concentration of hRES in each of plasma samples. Overall, normal hRES levels determined by RES-MSIA were found to be comparable to those selected and determined by ELISA. With regard to gender, female donor samples were slightly elevated over males. Four single cardiac samples were analyzed and found to have hRES concentrations approximately three times that of the normal. The recombinant-based RES-MSIA is rapid and is amendable to parallel high-throughput robotic processing of resistin related disease cohorts.


  • High‐throughput MS‐based protein phenotyping: Application to haptoglobin

    by Kemmons A. Tubbs, Urban A. Kiernan, Eric E. Niederkofler, Dobrin Nedelkov, Allan L. Bieber, Randall W. Nelson

    A high‐throughput affinity capture and reduction approach was developed for phenotype and post‐translational modification analysis of a complexed globular protein, haptoglobin (Hp), directly from human plasma. Hp was selectively retrieved utilizing anti‐Hp antibodies immobilized onto affinity pipette tips, eluted onto a formatted mass spectrometer target for reduction of Hp α‐chains (Hpα1 and Hpα2) and subjected to subsequent MALDI‐MS analysis. The affinity capture and reduction approach was originally developed from a pre‐extraction reduction methodology that was optimized to an affinity capture post‐reduction technique for intact Hp α‐chain variant analysis, phenotype classification and ensuing post‐translational variant detection. Three common Hp phenotypes (1–1, 2–1 and 2–2) were assigned according to detection of Hpα1 and/or Hpα2 reduced intact chain(s) average mass(es). The affinity capture post‐reduction approach was scaled for high‐throughput Hp α‐chain phenotype analysis from a normal plasma cohort. The entire sample cohort was successfully analyzed and phenotyped using the developed approach. Additionally, Hp post‐translational variants were detected and assigned via accurate MS analyses. The results of this study suggest use of the methodology in future analyses of other similarly complexed proteins and in normal versus disease cohort population proteomics studies.


  • Open Access

    Selected expression profiling of full-length proteins and their variants in human plasma

    by Urban A. Kiernan, Dobrin Nedelkov, Kemmons A. Tubbs, Eric E. Niederkofler, Randall W. Nelson